US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 38.570
  • +0.110+0.29%
Close Apr 26 16:00 ET
  • 37.130
  • -1.440-3.73%
Post 19:49 ET
4.90BMarket Cap18.37P/E (TTM)

Halozyme Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 25, 2024

Based on 9 analysts giving stock ratings to Halozyme Therapeutics in the past 3 months

Strong Buy

  • Buy

    77.78%

  • Hold

    22.22%

  • Sell

    0.00%

Price Target

Updated: Apr 25, 2024

The average Halozyme Therapeutics stock price target is 51.00 with a max estimate of 72.00 and a min estimate of 39.00

Review Halozyme Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 25, 2024

Strong Buy

  • Buy

    77.78%

  • Hold

    22.22%

  • Sell

    0.00%

Price Target

Updated: Apr 25, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg